Farfield Scientific Announces Pan-European Collaboration on Hepatitis Diagnostic Test
The identification and characterisation of suitable antibody interactions falls to the research group of Professor Heinz Zoller of the Hepatology Laboratory, Innsbruck Medical University, Austria, led by Professor Wolfgang Vogel.
"We look for viral infections and tumors. At present, routine diagnostic techniques must be performed in specialist laboratories." explains Professor Zoller. "Our first goal is detection of viral hepatitis, hepatocellular carcinoma and disturbances in iron metabolism."
Farfield's role has been to help quantify the coupling of these antigens to the waveguide surface using Farfield's patented Dual Polarisation Interferometry (DPI) technology, a technique which measures the quantity, structure and bioavailability of the captured antigens. Chemical and physical changes in the antigen are then tracked in real time such that the assay can be optimised.
Other news from the department research and development
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.